Showing results (141-150 of 182) with videos related to
Sort By:
Pageof 19
Medical Oncology (Northwood, London, England)|January 22, 2008
Effect of zoledronic acid on serum angiogenic factors in patients with bone metastasesFaruk Tas, Derya Duranyildiz, Hilal Oguz, et al.International Journal of Clinical Oncology|September 22, 2012
Performance status of patients is the major prognostic factor at all stages of pancreatic cancerFaruk Tas, Fatma Sen, Hatice Odabas, et al.Medical Oncology (Northwood, London, England)|April 5, 2011
The major stressful life events and cancer: stress history and cancerFaruk Tas, Umran Karalar, Mehmet Aliustaoglu, et al.Medical Oncology (Northwood, London, England)|March 8, 2005
Oxidative stress in breast cancerFaruk Tas, Hasan Hansel, Ahmet Belce, et al.Medical Oncology (Northwood, London, England)|November 2, 2005
Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancerFaruk Tas, Derya Duranyildiz, Andac Argon, et al.American Journal of Clinical Oncology|June 1, 2004
Clinical value of protein S100 and melanoma-inhibitory activity (MIA) in malignant melanomaFaruk Tas, Vildan Yasasever, Derya Duranyildiz, et al.Medical Oncology (Northwood, London, England)|August 20, 2005
The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanomaFaruk Tas, Hilal Oguz, Andaç Argon, et al.American Journal of Clinical Oncology|April 11, 2002
Prognostic role of nm23 gene expression in patients with ovarian cancerFaruk Tas, Sitki Tuzlali, Adnan Aydiner, et al.Asian Pacific Journal of Cancer Prevention : APJCP|March 28, 2017
Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma PatientsFaruk Tas, Senem Karabulut, Hulya Guveli, et al.Medical Oncology (Northwood, London, England)|June 21, 2005
Apoptosis of lymphocytes in peripheral blood of patients with melanomaFaruk Tas, Derya Duranyildiz, Andac Argon, et al.Pageof 19